ドブタミンの世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)

GlobalInfoResearchが発行した調査報告書(GIR9071918)
◆英語タイトル:Global Dobutamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
◆商品コード:GIR9071918
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2019年6月(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、ドブタミンの世界市場について調べ、まとめました。種類別セグメントは、注射剤200mg、注射剤250mg等、用途別セグメントは、慢性心不全、心筋梗塞、術後低血圧、その他等に区分しました。ドブタミンの世界市場概観、企業動向、企業別ドブタミンシェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・ドブタミンの市場概観
・ドブタミンの企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・ドブタミンの企業別販売動向、市場シェア、市場集中度、競争動向
・ドブタミンの世界市場規模
・ドブタミンの北米市場分析(アメリカ、カナダ、メキシコ等)
・ドブタミンのアメリカ市場規模推移
・ドブタミンのカナダ市場規模推移
・ドブタミンのメキシコ市場規模推移
・ドブタミンのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・ドブタミンのドイツ市場規模推移
・ドブタミンのイギリス市場規模推移
・ドブタミンのロシア市場規模推移
・ドブタミンのアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・ドブタミンの日本市場規模推移
・ドブタミンの中国市場規模推移
・ドブタミンの韓国市場規模推移
・ドブタミンのインド市場規模推移
・ドブタミンの東南アジア市場規模推移
・ドブタミンの南米市場分析(ブラジル、アルゼンチン等)
・ドブタミンの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・ドブタミンの種類別分析/販売量、売上、市場シェア(注射剤200mg、注射剤250mg)
・ドブタミンの用途別分析/市場規模(慢性心不全、心筋梗塞、術後低血圧、その他)
・ドブタミンの市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・ドブタミンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The worldwide market for Dobutamine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dobutamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Ivax Pharmaceuticals 
Physicians Total Care
Baxter Healthcare 
Sanofi
Teva Canada
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection 200mg
Injection 250mg

Market Segment by Applications, can be divided into
Chronic Heart Failure
Myocardial Infarction
Postoperative Hypotension
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dobutamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dobutamine, with price, sales, revenue and global market share of Dobutamine in 2017 and 2018.
Chapter 3, the Dobutamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dobutamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dobutamine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dobutamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Dobutamine Introduction
1.2 Market Analysis by Type
1.2.1 Injection 200mg
1.2.2 Injection 250mg
1.3 Market Analysis by Applications
1.3.1 Chronic Heart Failure
1.3.2 Myocardial Infarction
1.3.3 Postoperative Hypotension
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ivax Pharmaceuticals 
2.1.1 Business Overview
2.1.2 Dobutamine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ivax Pharmaceuticals  Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Physicians Total Care
2.2.1 Business Overview
2.2.2 Dobutamine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Physicians Total Care Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Baxter Healthcare 
2.3.1 Business Overview
2.3.2 Dobutamine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Baxter Healthcare  Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Dobutamine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Canada
2.5.1 Business Overview
2.5.2 Dobutamine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Canada Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Dobutamine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bedford Laboratories
2.7.1 Business Overview
2.7.2 Dobutamine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bedford Laboratories Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Dobutamine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sterimax
2.9.1 Business Overview
2.9.2 Dobutamine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sterimax Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Teligent
2.10.1 Business Overview
2.10.2 Dobutamine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teligent Dobutamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dobutamine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Dobutamine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Dobutamine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Dobutamine Manufacturer Market Share in 2018
3.3.2 Top 6 Dobutamine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Dobutamine Market Analysis by Regions
4.1 Global Dobutamine Sales, Revenue and Market Share by Regions
4.1.1 Global Dobutamine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Dobutamine Revenue and Market Share by Regions (2014-2019)
4.2 North America Dobutamine Sales and Growth Rate (2014-2019)
4.3 Europe Dobutamine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Dobutamine Sales and Growth Rate (2014-2019)
4.5 South America Dobutamine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Dobutamine Sales and Growth Rate (2014-2019)
5 North America Dobutamine by Country
5.1 North America Dobutamine Sales, Revenue and Market Share by Country
5.1.1 North America Dobutamine Sales and Market Share by Country (2014-2019)
5.1.2 North America Dobutamine Revenue and Market Share by Country (2014-2019)
5.2 United States Dobutamine Sales and Growth Rate (2014-2019)
5.3 Canada Dobutamine Sales and Growth Rate (2014-2019)
5.4 Mexico Dobutamine Sales and Growth Rate (2014-2019)
6 Europe Dobutamine by Country
6.1 Europe Dobutamine Sales, Revenue and Market Share by Country
6.1.1 Europe Dobutamine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Dobutamine Revenue and Market Share by Country (2014-2019)
6.2 Germany Dobutamine Sales and Growth Rate (2014-2019)
6.3 UK Dobutamine Sales and Growth Rate (2014-2019)
6.4 France Dobutamine Sales and Growth Rate (2014-2019)
6.5 Russia Dobutamine Sales and Growth Rate (2014-2019)
6.6 Italy Dobutamine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Dobutamine by Country
7.1 Asia-Pacific Dobutamine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Dobutamine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Dobutamine Revenue and Market Share by Country (2014-2019)
7.2 China Dobutamine Sales and Growth Rate (2014-2019)
7.3 Japan Dobutamine Sales and Growth Rate (2014-2019)
7.4 Korea Dobutamine Sales and Growth Rate (2014-2019)
7.5 India Dobutamine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Dobutamine Sales and Growth Rate (2014-2019)
8 South America Dobutamine by Country
8.1 South America Dobutamine Sales, Revenue and Market Share by Country
8.1.1 South America Dobutamine Sales and Market Share by Country (2014-2019)
8.1.2 South America Dobutamine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Dobutamine Sales and Growth Rate (2014-2019)
8.3 Argentina Dobutamine Sales and Growth Rate (2014-2019)
8.4 Colombia Dobutamine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Dobutamine by Countries
9.1 Middle East and Africa Dobutamine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Dobutamine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Dobutamine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Dobutamine Sales and Growth Rate (2014-2019)
9.3 Turkey Dobutamine Sales and Growth Rate (2014-2019)
9.4 Egypt Dobutamine Sales and Growth Rate (2014-2019)
9.5 Nigeria Dobutamine Sales and Growth Rate (2014-2019)
9.6 South Africa Dobutamine Sales and Growth Rate (2014-2019)
10 Global Dobutamine Market Segment by Type
10.1 Global Dobutamine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Dobutamine Sales and Market Share by Type (2014-2019)
10.1.2 Global Dobutamine Revenue and Market Share by Type (2014-2019)
10.2 Injection 200mg Sales Growth and Price
10.2.1 Global Injection 200mg Sales Growth (2014-2019)
10.2.2 Global Injection 200mg Price (2014-2019)
10.3 Injection 250mg Sales Growth and Price
10.3.1 Global Injection 250mg Sales Growth (2014-2019)
10.3.2 Global Injection 250mg Price (2014-2019)
11 Global Dobutamine Market Segment by Application
11.1 Global Dobutamine Sales Market Share by Application (2014-2019)
11.2 Chronic Heart Failure Sales Growth (2014-2019)
11.3 Myocardial Infarction Sales Growth (2014-2019)
11.4 Postoperative Hypotension Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Dobutamine Market Forecast (2019-2024)
12.1 Global Dobutamine Sales, Revenue and Growth Rate (2019-2024)
12.2 Dobutamine Market Forecast by Regions (2019-2024)
12.2.1 North America Dobutamine Market Forecast (2019-2024)
12.2.2 Europe Dobutamine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Dobutamine Market Forecast (2019-2024)
12.2.4 South America Dobutamine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Dobutamine Market Forecast (2019-2024)
12.3 Dobutamine Market Forecast by Type (2019-2024)
12.3.1 Global Dobutamine Sales Forecast by Type (2019-2024)
12.3.2 Global Dobutamine Market Share Forecast by Type (2019-2024)
12.4 Dobutamine Market Forecast by Application (2019-2024)
12.4.1 Global Dobutamine Sales Forecast by Application (2019-2024)
12.4.2 Global Dobutamine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ドブタミンの世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)(Global Dobutamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。